Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	ZBHZimmer Biomet	STESteris	RVTYRevvity
Snapshot
Price	$93.67	$209.01	$143.07
Market cap	$17.28B	$21.27B	$12.69B
Valuation
P/E	23.8x	26.1x	67x
Forward P/E	27.9x	20.4x	74.9x
Growth
Revenue growth	9.2%	8.7%	4.8%
EPS growth	-14.6%	27.9%	-10.7%
Profitability
Net margin	9.1%	13.2%	8.3%
ROE	6.0%	11.1%	3.3%
Balance sheet & cash
Debt / equity	0.59x	0.27x	0.44x
Free cash flow yield	7.5%	5.4%	5.1%
Dividend yield	1.0%	1.2%	0.3%
Verdict
Investment rating	Neutral· 50	Favorable· 59	Weak· 30

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	ZBHtoday $94	STEtoday $209	RVTYtoday $143
2027	$71.66 – $105.10+12% CAGR	$200.57 – $294.17+41% CAGR	$109.45 – $160.52+12% CAGR
2028	$73.09 – $107.20+7% CAGR	$256.63 – $376.39+34% CAGR	$111.64 – $163.74+7% CAGR
2029	$74.55 – $109.34+5% CAGR	$328.36 – $481.59+32% CAGR	$113.87 – $167.01+5% CAGR
2030	$76.04 – $111.53+4% CAGR	$420.14 – $616.20+31% CAGR	$116.15 – $170.35+4% CAGR
2031	$77.56 – $113.76+4% CAGR	$537.56 – $788.43+30% CAGR	$118.47 – $173.76+4% CAGR
5-yr CAGR	-3.7% – 4.0%	20.8% – 30.4%	-3.7% – 4.0%